Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
3288
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q1A261 (Created: 2006-09-05 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
ENV_SIVMB
Protein Name
Envelope glycoprotein gp160
Gene
env
Organism Scientific
Simian immunodeficiency virus (isolate MB66)
Organism Common
SIV-cpz
Lineage
Viruses
Retro-transcribing viruses
Retroviridae
Orthoretrovirinae
Lentivirus
Primate lentivirus group
Protein Length [aa]
880
Protein Mass [Da]
99656
Features
Type
Description
Status
Start
End
signal peptide
potential
1
33
chain
Envelope glycoprotein gp160
34
880
chain
Surface protein
by similarity
34
527
chain
Transmembrane protein
by similarity
528
880
disulfide bond
by similarity
57
77
disulfide bond
by similarity
122
229
disulfide bond
by similarity
129
220
disulfide bond
by similarity
134
174
disulfide bond
by similarity
242
271
disulfide bond
by similarity
252
263
disulfide bond
by similarity
319
353
disulfide bond
by similarity
403
461
disulfide bond
by similarity
410
434
transmembrane region
potential
701
721
topological domain
Extracellular
potential
34
700
topological domain
Cytoplasmic
potential
722
880
region of interest
V1
by similarity
134
173
region of interest
V2
by similarity
174
220
region of interest
V3
by similarity
319
352
region of interest
V4
by similarity
410
434
region of interest
V5
by similarity
480
487
region of interest
Fusion peptide
potential
528
548
region of interest
Immunosuppression
by similarity
593
609
glycosylation site
N-linked (GlcNAc...)
potential
91
91
glycosylation site
N-linked (GlcNAc...)
potential
133
133
glycosylation site
N-linked (GlcNAc...)
potential
145
145
glycosylation site
N-linked (GlcNAc...)
potential
148
148
glycosylation site
N-linked (GlcNAc...)
potential
157
157
glycosylation site
N-linked (GlcNAc...)
potential
163
163
glycosylation site
N-linked (GlcNAc...)
potential
173
173
glycosylation site
N-linked (GlcNAc...)
potential
177
177
glycosylation site
N-linked (GlcNAc...)
potential
221
221
glycosylation site
N-linked (GlcNAc...)
potential
256
256
glycosylation site
N-linked (GlcNAc...)
potential
265
265
glycosylation site
N-linked (GlcNAc...)
potential
286
286
glycosylation site
N-linked (GlcNAc...)
potential
299
299
glycosylation site
N-linked (GlcNAc...)
potential
312
312
glycosylation site
N-linked (GlcNAc...)
potential
318
318
glycosylation site
N-linked (GlcNAc...)
potential
324
324
glycosylation site
N-linked (GlcNAc...)
potential
356
356
glycosylation site
N-linked (GlcNAc...)
potential
372
372
glycosylation site
N-linked (GlcNAc...)
potential
381
381
glycosylation site
N-linked (GlcNAc...)
potential
411
411
glycosylation site
N-linked (GlcNAc...)
potential
417
417
glycosylation site
N-linked (GlcNAc...)
potential
423
423
glycosylation site
N-linked (GlcNAc...)
potential
429
429
glycosylation site
N-linked (GlcNAc...)
potential
464
464
glycosylation site
N-linked (GlcNAc...)
potential
479
479
glycosylation site
N-linked (GlcNAc...)
potential
628
628
glycosylation site
N-linked (GlcNAc...)
potential
633
633
glycosylation site
N-linked (GlcNAc...)
potential
642
642
glycosylation site
N-linked (GlcNAc...)
potential
654
654
site
Cleavage; by host furin
by similarity
527
528
short sequence motif
YXXL motif; contains endocytosis signal
by similarity
729
732
coiled-coil region
potential
559
609
coiled-coil region
potential
650
684
SP Length
33
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MKAMETQRNCRTLSLKEIILCTLVLGIIGIIKC
Sequence
MKAMETQRNCRTLSLKEIILCTLVLGIIGIIKC
EDNMWVTVYYGVPVWRE
ADTTLFCASDAKAQNPEVHNVWASQACVSTNPNPEEIELT
N
VTEYFNAWE
NNMVEQMHEDIVNLWDQSVKPCVKLIPLCVTL
N
CSLFKCIKENG
N
TT
N
CT
VQISTG
N
DSTAN
N
ITVGTIDMY
N
CSF
N
ATTELRDRKKQVYSLFYRQDLEP
LEGNKPPEGDKNALYRLYNC
N
TTAMTQACSKVSLEPIPIHYCAPAGFALL
KCNDK
N
FTGIGQCK
N
VSTVHCTHGIRPVVSTQFLL
N
GTLEEKVTVLDR
N
V
SNDMDTIIVKL
N
ETVRL
N
CTRTG
N
NTIKGIPIGPSQIFYGIETVIGDTRQ
AF
CQL
N
KTVWTNTFKKVRHAL
N
ETYKGYLG
N
ETITFGPSTGGDLEVTNLH
LICGGEFFY
C
N
TSILF
N
TSIIF
N
ETKDD
N
ITIPC
RIRQIVRLWQRVGRGI
FLPPIRGTINCIS
N
ITGILFAQQKTDRM
N
KSAMFTPV
GGEMRNNWRSELY
KYKVVRIEPLGVAPTKAKRRTVHREK
RA
AVGLGALFLGFLGAAGSTMG
AA
SLTLTVQA
RQLLSGIVQQQSNLLRAIEAQQHLLQLSVWGIKQLQARVLAV
ERYLKDQQL
LGLWGCSGKLICTTSVPW
N
TTWT
N
KSYDDIWY
N
MTWMQWD
K
EVSNYTDVIYNLLEKAQTQQENNEKELLELDKWA
SLWNWFDITSWLWYIK
IFIIIVGGLIGLRIVFALLSI
VNRVRQG
YSPL
SFQTLIPARRDRDRPEEI
EEGGGEPDNVRSIRLVSGFLALAWNDLRDLCLFLYHRLRDLLLIVLRTLE
LVGQTLLKGLRRGREALIHLRGILQYWGQELKTSAISLLDTTAIAVAEGT
DRIIEIAQRFGRGILNIPRRIRQGLERALL
Original
MKAMETQRNCRTLSLKEIILCTLVLGIIGIIKCEDNMWVTVYYGVPVWRE
ADTTLFCASDAKAQNPEVHNVWASQACVSTNPNPEEIELTNVTEYFNAWE
NNMVEQMHEDIVNLWDQSVKPCVKLIPLCVTLNCSLFKCIKENGNTTNCT
VQISTGNDSTANNITVGTIDMYNCSFNATTELRDRKKQVYSLFYRQDLEP
LEGNKPPEGDKNALYRLYNCNTTAMTQACSKVSLEPIPIHYCAPAGFALL
KCNDKNFTGIGQCKNVSTVHCTHGIRPVVSTQFLLNGTLEEKVTVLDRNV
SNDMDTIIVKLNETVRLNCTRTGNNTIKGIPIGPSQIFYGIETVIGDTRQ
AFCQLNKTVWTNTFKKVRHALNETYKGYLGNETITFGPSTGGDLEVTNLH
LICGGEFFYCNTSILFNTSIIFNETKDDNITIPCRIRQIVRLWQRVGRGI
FLPPIRGTINCISNITGILFAQQKTDRMNKSAMFTPVGGEMRNNWRSELY
KYKVVRIEPLGVAPTKAKRRTVHREKRAAVGLGALFLGFLGAAGSTMGAA
SLTLTVQARQLLSGIVQQQSNLLRAIEAQQHLLQLSVWGIKQLQARVLAV
ERYLKDQQLLGLWGCSGKLICTTSVPWNTTWTNKSYDDIWYNMTWMQWDK
EVSNYTDVIYNLLEKAQTQQENNEKELLELDKWASLWNWFDITSWLWYIK
IFIIIVGGLIGLRIVFALLSIVNRVRQGYSPLSFQTLIPARRDRDRPEEI
EEGGGEPDNVRSIRLVSGFLALAWNDLRDLCLFLYHRLRDLLLIVLRTLE
LVGQTLLKGLRRGREALIHLRGILQYWGQELKTSAISLLDTTAIAVAEGT
DRIIEIAQRFGRGILNIPRRIRQGLERALL
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11